Melbourne, Australia

Silviu Itescu

This inventor holds 31 USPTO granted patents and 43 published patent applications, plus 4 CIPO patents and 19 EPO patents, primarily in Stem Cell Therapy. Top assignees: Mesoblast, Inc, Mesoblast International Sarl, Oaktree Fund Administration, LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silviu Itescu. Retrieved from https://idiyas.com/inventor/silviu-itescu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 93.5

 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 50(Granted Patents)


Location History:

  • Victoria, AU (2014)
  • Melbourne, AU (2014 - 2023)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Visual Acuity
Inflammatory Lung Diseases
Mesenchymal Stem Cells
Cancer Treatment
Heart Failure
Graft Versus Host Disease
Obesity
Metabolic Syndrome
Osteoblastic Function
Haemopoietic Precursors
Respiratory Conditions
Rheumatic Disease
31 patents (USPTO):Explore Patents

Title: Innovations in Heart Failure Treatment: The Contributions of Silviu Itescu

Introduction

Silviu Itescu, an esteemed inventor located in Melbourne, Australia, has made significant strides in the medical field, particularly in the treatment and prevention of heart failure. With 25 patents to his name, his work reflects a profound commitment to advancing cardiac health and improving patient outcomes.

Latest Patents

Among his latest inventions, Itescu has developed methods aimed at preventing progressive heart failure in subjects with persistent left ventricular (LV) dysfunction. His patent details methods that also target patients with a proximal left anterior descending (LAD) lesion coupled with persistent left ventricular dysfunction. Additionally, he has introduced a method for treating heart failure in patients who exhibit elevated left ventricular end systolic volume (LVESV), specifically focusing on those with LVESV greater than 70 ml.

Career Highlights

Silviu Itescu has held pivotal roles in several prominent organizations, including Mesoblast, Inc. and Mesoblast International Sarl. His tenure at these companies highlights his innovative approach to medical technology and demonstrates his ability to translate complex scientific principles into practical applications aimed at improving heart failure management.

Collaborations

Throughout his career, Itescu has collaborated with esteemed colleagues such as Ravi Krishnan and Michael David Schuster. These partnerships have been instrumental in fostering innovative solutions and advancing research in cardiovascular health.

Conclusion

Silviu Itescu's contributions to the medical field, particularly through his patents, showcase his dedication to combating heart failure. His work not only highlights his expertise as an inventor but also signifies the importance of innovation in developing effective treatment strategies for patients suffering from cardiovascular conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…